Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05150704 · ClinicalTrials.gov registry record · Phase 3
MYTHS - MYocarditis THerapy With Steroids
A Phase 3 study of Myocarditis Acute, sponsored by Niguarda Hospital.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 288
- Enrollment target
- 20
- Study locations
NCT05150704 is a Phase 3 study of Myocarditis Acute that is actively recruiting participants, run by Niguarda Hospital. The registered enrollment target is 288 participants. The trial reports 20 study locations across 4 states.
The verdict
NCT05150704, a Phase 3 study of Myocarditis Acute, is actively recruiting participants, sponsored by Niguarda Hospital.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 288 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a phase III, multi-center international, single blind randomized controlled trial to test the efficacy of pulsed intravenous (IV) methylprednisolone versus standard therapy on top of maximal support in patients with Acute myocarditis (AM).
Conditions Studied
Interventions
- DRUG Methylprednisolone
- DRUG saline solution
Study Locations (20)
Other
- Medical University of Graz - Graz
- Medical University Innsbruck - Innsbruck
- Medical University of Wien - Vienna
- Onze Lieve Vrouwziekenhuis - Aalst
- Antwerp University Hospital - Edegem
- Jessa Hospital Hasselt - Hasselt
- University Hospitals Leuven - Leuven
- Masaryk University and St. Anne's University Hospital - Brno
- Charles University in Prague and General University Hospital - Prague
- Institute for Clinical and Experimental Medicine - IKEM - Prague
- Heart and Lung Center, Helsinki University Hospital - Helsinki
- AOU Ospedali Riuniti Umberto I°-Lancisi-Salesi di Ancona - Ancona
- ASST Papa Giovanni XXIII - Bergamo
- Policlinico S.Orsola-Malpighi - Bologna
- ASST Spedali Civili - Brescia
- Azienda Ospedaliera "G.Brotzu" - Cagliari
Virginia
- University of Virginia - Charlottesville
- Virginia Commonwealth University - Richmond
California
- University of California San Diego - San Diego
Texas
- University of Texas - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2021-10-07 |
| Est. Completion | 2028-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05150704
The ClinicalTrials.gov registry entry for NCT05150704 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Niguarda Hospital, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myocarditis Acute appearing as the primary indexed condition, and to 2 interventions - of which Methylprednisolone is the first listed.
NCT05150704 reports 20 study locations spanning 4 distinct geographic areas - top geographies include Other, Virginia, California.
Frequently Asked Questions
What is clinical trial NCT05150704 about?
NCT05150704 is a clinical study titled "MYTHS - MYocarditis THerapy With Steroids". This is a phase III, multi-center international, single blind randomized controlled trial to test the efficacy of pulsed intravenous (IV) methylprednisolone versus standard therapy on top of maximal support in patients with Acute myocarditis (AM).
What is the current status of trial NCT05150704?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 288 participants. The study started on 2021-10-07. Estimated completion is 2028-12.
What conditions does trial NCT05150704 study?
This clinical trial studies the following conditions: Myocarditis Acute.
What interventions are being tested in trial NCT05150704?
The interventions under investigation include: Methylprednisolone (DRUG), saline solution (DRUG).
Who is sponsoring clinical trial NCT05150704?
This trial is sponsored by Niguarda Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05150704 being conducted?
This trial has 20 study locations across California, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocarditis Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.